Microwave‐accelerated preparation and analytical characterization of 5‐ethoxy‐N,N‐dialkyl‐[α,α,β,β‐H4]‐ and [α,α,β,β‐D4]‐tryptamines
Ruchanok Tearavarich, Viwat Hahnvajanawong, Nicola M. Dempster, Paul F. Daley, Nicholas V. Cozzi, Simon D. Brandt
Drug Testing and Analysis December 29, 2010 DOI: 10.1002/dta.223 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Synthesis and characterization Peer reviewed |
|---|---|
| Keywords | Tryptamines Iminium Tetrahydrofuran Mass spectrometry Alkoxy group Solvent Analytical chemistry journal Ion Alkyl Chromatography Organic chemistry |
| Citations | 10 |
| Key points | Twelve novel 5-ethoxy-N,N-dialkyl-tryptamines and their deuterated counterparts were synthesized rapidly via microwave-accelerated reduction and characterized by spectroscopy and mass spectrometry. |
Abstract
The increased interest in N,N-dialkyl tryptamines is a reflection of their diverse range of biologically active properties. Deuterated derivatives are of interest for use as internal standards in bioanalytical or pharmacological assays. The present study reports on the synthesis of twelve novel 5-ethoxy-N,N-dialkyl-[α,α,β,β-H(4) ]-tryptamines and their [α,α,β,β-D(4) ]-counterparts following the Speeter and Anthony procedure. The normally time-consuming reduction step was carried out in 5 min under microwave-accelerated conditions. Good yields were obtained using tetrahydrofuran as the solvent at 150 °C. The resulting 24 tryptamines have been characterized by 1D/2D nuclear magnetic resonance spectroscopy and gas chromatography ion trap mass spectrometry. Differential fragmentation of side-chain-related iminium ions has been observed as a key principle. Because many N,N-dialkyltryptamines are available outside of traditional pharmaceutical supply chains as so-called 'research chemicals', the availability, as standards, of these new N,N-dialkyltryptamines will aid in identifiying novel tryptamines arising from these other souces. They should therefore be of immediate value within forensic, research, and public health contexts.
Citations in the library
Cited by 5
- Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives. Drug Testing and Analysis 2017
- Synthesis and characterization of high‐purity N,N‐dimethyltryptamine hemifumarate for human clinical trials Drug Testing and Analysis July 1, 2020
- Synthesis and characterization of 5‐methoxy‐2‐methyl‐N,N‐dialkylated tryptamines Drug Testing and Analysis 2012
- Special issue on illicit drugs Drug Testing and Analysis September 1, 2011
- Serotonin 2A receptor binding, functional activity, and in vitro metabolism of two trideuteromethoxy 2C-B isotopologues. Naunyn-Schmiedeberg's Archives of Pharmacology June 18, 2026
Cites 22
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
- Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder The Journal of Clinical Psychiatry November 15, 2006
- The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator Science February 13, 2009
- Psychedelics and the Human Receptorome PLoS One 2010
and 17 more in the library